SQZ Biotechnologies Company
SQZB
$0.04
$0.01242.86%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -94.46% | -- | -3.30% | -27.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -94.46% | -- | -3.30% | -27.40% |
| Cost of Revenue | -46.49% | -32.15% | -23.72% | -9.43% | -4.33% |
| Gross Profit | 35.08% | 19.26% | 8.24% | 25.04% | -2.63% |
| SG&A Expenses | -18.86% | -34.51% | -23.63% | -20.72% | 3.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.29% | -32.79% | -23.69% | -12.69% | -2.43% |
| Operating Income | 30.22% | 23.97% | 13.29% | 22.49% | -2.86% |
| Income Before Tax | -4.40% | 24.58% | 15.93% | -14.59% | -0.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.40% | 24.58% | 15.93% | -14.59% | -0.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.40% | 24.58% | 15.93% | -14.59% | -0.86% |
| EBIT | 30.22% | 23.97% | 13.29% | 22.49% | -2.86% |
| EBITDA | 32.12% | 23.89% | 13.17% | 26.45% | -2.97% |
| EPS Basic | -3.67% | 27.47% | 19.77% | -9.16% | 3.40% |
| Normalized Basic EPS | 30.02% | 27.45% | 19.78% | 29.99% | 3.38% |
| EPS Diluted | -3.67% | 27.47% | 19.77% | -9.16% | 3.40% |
| Normalized Diluted EPS | 30.02% | 27.45% | 19.78% | 29.99% | 3.38% |
| Average Basic Shares Outstanding | 0.71% | 3.96% | 4.78% | 4.97% | 4.40% |
| Average Diluted Shares Outstanding | 0.71% | 3.96% | 4.78% | 4.97% | 4.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |